CRX.L Regulatory News (CRX)

13 Feb 2007 07:01

Cyprotex PLC13 February 2007 13 February, 2007 Cyprotex PLC (the "Company" or "Cyprotex") REQUISITION OF EXTRAORDINARY GENERAL MEETING Cyprotex PLC ("the Company") received a requisition on 12 February, 2007 fromDr. David Leahy and Robert Long, being shareholders of the Company holding notless than one tenth of the paid up share capital of the Company, to hold anextraordinary general meeting of the Company pursuant to section 368 of theCompanies Act 1985. The purpose of the meeting is:- 1. to propose separate resolutions to remove each of RobertAtwater, Martial Lacroix, Minhaz Manji, David Evans, Nikolas Sofronis andRussell Gibbs as directors of the Company with immediate effect notwithstandingthat the terms of their respective offices have not yet expired; and 2. to propose separate resolutions to appoint Dr. DavidCavalla, Dr. David Leahy, Michael McGoun and Robert Long as directors of theCompany with immediate effect. The Board is seeking clarification from the requisitionists of the background tothe requisition. In the meantime the board is pleased to report that it has received indicationsof support from other shareholders representing more than 50% of the paid upshare capital of the Company. For further information, please contact:- Robert AtwaterCyprotex PLCTel: 01625 505 100Email: ir@cyprotex.com or Russell GibbsCyprotex PLCTel: 01625 505 100Email: ir@cyprotex.com or Charles WalkerNomura Code Securities LimitedTel: +44 (0) 20 7776 1200cew@nomuracode.comhttp://www.nomuracode.com/ For media enquires, please contact: WMC CommunicationsCharlie Geller/Alex GloverTel: +44 (0) 20 7930 9030charlie.geller@wmccommunications.com This information is provided by RNS The company news service from the London Stock Exchange